DJIA 17,329.25 -87.60 -0.50%
NASDAQ 4,677.67 -5.74 -0.12%
S&P 500 2,015.47 -5.78 -0.29%
market minute promo

Express Scripts (NASDAQ: ESRX)

81.37 -0.91 (-1.11%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ESRX $81.51 -0.94%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $81.87
Previous Close $82.28
Daily Range $80.75 - $82.48
52-Week Range $64.64 - $86.64
Market Cap $59.7B
P/E Ratio 32.91
Dividend (Yield) $0.00 (0.0%)
Volume 1,936,470
Average Daily Volume 4,218,020
Current FY EPS $4.88

Sector

Healthcare

Industry

Healthcare Information Services

Express Scripts (ESRX) Description

Provides pharmacy benefit management services, including retail drug card programs, mail pharmacy services, drug formulary management programs and other clinical management programs for HMOs, health insurers, third-party administrators and employers. Website: http://www.express-scripts.com/

News & Commentary Rss Feed

Pfizer, Inc. Should Forget AstraZeneca and Buy This Company Instead

3 Motley Fool contributors offer up suggestions on what they believe Pfizer should acquire.

Baird Remains Buyers Of Gilead Before Earnings Release

PetMed Express, Inc. (PETS) Ex-Dividend Date Scheduled for January 30, 2015

Cramer Gives His Opinion On Whole Foods Market, Whiting Petroleum And Express Scripts

Top Analyst Upgrades and Downgrades: AOL, Caterpillar, Goodyear, Southwest, Synchrony, Yahoo and Mor

Top Analyst Upgrades and Downgrades: AOL, Caterpillar, Goodyear, Southwest, Synchrony, Yahoo and More

These 3 Dividend Stocks Could Crush the Market in 2015

AbbVie, Amgen, and Pfizer are three dividend stocks that could crush the broader market this year. Here's why.

Has Gilead Sciences Been Able To Maintain Its Lead Run In The Face Of Competition?

Why Drug Pricing Could Bring Volatility To The Biotech Sector This Year

AbbVie Gains EU Approval for Hepatitis C Virus Treatment - Analyst Blog

AbbVie Gains EU Approval for Hepatitis C Virus Treatment - Analyst Blog

Gilead: A Bullish Update

See More ESRX News...

ESRX's Top Competitors

ESRX $81.37 (-1.11%)
Current stock: ESRX
UNH $107.76 (-1.49%)
Current stock: UNH
ANTM $136.35 (-0.55%)
Current stock: ANTM
FMS $37.23 (-0.43%)
Current stock: FMS